Castleman Breaux 4
4 · IONIS PHARMACEUTICALS INC · Filed Jun 29, 2020
Insider Transaction Report
Form 4
Castleman Breaux
Director
Transactions
- Sale
Common Stock
2020-06-25$60.00/sh−10,000$600,000→ 15,183 total - Exercise/Conversion
Common Stock
2020-06-25$26.66/sh+10,000$266,600→ 25,183 total - Exercise/Conversion
Director Stock Option (right to buy)
2020-06-25−10,000→ 12,500 totalExercise: $26.66From: 2017-06-25Exp: 2023-06-24→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on March 5, 2020.